Lifecare ASA Logo

Lifecare ASA

LIFE | OL

Overview

Corporate Details

ISIN(s):
NO0013250563 (+2 more)
LEI:
254900D88MYGZ7JD5P39
Country:
Norway
Address:
Ytrebygdsvegen 215, 5158 Bergen
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Lifecare ASA is a clinical-stage medical sensor company developing proprietary nanotechnology for medical monitoring. Its core Sencell technology utilizes osmotic pressure to enable miniaturized, implantable nanobiosensors that can measure various body analytes. The company's primary focus is on diabetes management, with the goal of creating a next-generation Continuous Glucose Monitoring (CGM) system that is painless, accurate, and offers long-term use for both human and veterinary patients. Lifecare is advancing its technology through clinical development and process automation to achieve regulatory approval and commercialization. The company also licenses its technology platform for broader medical and lifestyle applications.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Lifecare ASA. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-20 07:00
Investor Presentation
LIFE: Lifecare ASA Q2 2025 results - Attachment: Lifecare Q2 2025 Presentation.…
English 2.5 MB
2025-08-20 07:00
Quarterly Report
LIFE: Lifecare ASA Q2 2025 results - Attachment: Lifecare Q2 2025 Report.pdf
English 742.4 KB
2025-08-20 07:00
Earnings Release
LIFE: Lifecare ASA Q2 2025 results
English 4.1 KB
2025-08-13 07:47
Regulatory News Service
Lifecare advances CE mark preparation for its groundbreaking medical device - A…
English 57.3 KB
2025-08-13 07:47
Regulatory News Service
Lifecare advances CE mark preparation for its groundbreaking medical device
English 4.1 KB
2025-08-12 14:35
Report Publication Announcement
Lifecare ASA (LIFE): Invitation to presentation of Q2 2025 results 20 August at…
English 60.8 KB
2025-08-12 14:35
Report Publication Announcement
Lifecare ASA (LIFE): Invitation to presentation of Q2 2025 results 20 August at…
English 1.8 KB
2025-08-05 07:00
Regulatory News Service
Lifecare receives ethics approval to initiate first-in-human trial in Norway - …
English 56.7 KB
2025-08-05 07:00
Legal Proceedings Report
Lifecare receives ethics approval to initiate first-in-human trial in Norway
English 3.3 KB
2025-07-08 07:00
Regulatory News Service
Lifecare achieves full radio frequency compliance for CGM implant clearing th…
English 57.9 KB
2025-07-08 07:00
Regulatory News Service
Lifecare achieves full radio frequency compliance for CGM implant clearing th…
English 3.9 KB
2025-07-01 07:00
Regulatory News Service
Lifecare advances electromagnetic compatibility compliance testing for CGM impl…
English 56.0 KB
2025-07-01 07:00
Regulatory News Service
Lifecare advances electromagnetic compatibility compliance testing for CGM impl…
English 3.2 KB
2025-06-25 14:10
Share Issue/Capital Change
Lifecare ASA: Share capital increase registered - Attachment: Lifecare ASA- Sha…
English 63.0 KB
2025-06-25 14:10
Share Issue/Capital Change
Lifecare ASA: Share capital increase registered
English 1.9 KB

Automate Your Workflow. Get a real-time feed of all Lifecare ASA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Lifecare ASA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Theradiag Logo
Develops IVD tests for biotherapy monitoring in autoimmune diseases and oncology.
France ALTER
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
Developing disruptive spinal fixation devices for the vertebral surgery market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
Global provider of medical devices and genetic testing services for the IVF treatment journey.
Sweden VITR
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO
Ypsomed Holding AG Logo
Develops injection systems for self-medication, partnering with pharma and biotech firms.
Switzerland YPSN